Addiction markets: the case of high-dose buprenorphine in France

Les marché de l'addiction: l'exemple de la burénorphine à haut-dosage en France

Anne M Lovell ()
Additional contact information
Anne M Lovell: CERMES3 - UMR 8211 / U988 / UM 7 - CERMES3 - Centre de recherche Médecine, sciences, santé, santé mentale, société - EHESS - École des hautes études en sciences sociales - UPD5 - Université Paris Descartes - Paris 5 - INSERM - Institut National de la Santé et de la Recherche Médicale - CNRS - Centre National de la Recherche Scientifique

Post-Print from HAL

Keywords: addiction; drug markets; social movements; buprenorphine; France (search for similar items in EconPapers)
Date: 2006
Note: View the original document on HAL open archive server: https://hal.science/hal-03982722
References: View complete reference list from CitEc
Citations:

Published in Adriana Petryna; Andrew Lakoff; Arthur Kleinman. Global Pharmaceuticals: Ethics, Markets, Practices., Duke University Press, pp.136-170, 2006, 978-0822337416. ⟨10.1215/9780822387916-006⟩

Downloads: (external link)
https://hal.science/hal-03982722/document (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-03982722

DOI: 10.1215/9780822387916-006

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().